40
A. Husain et al. / Polyhedron 30 (2011) 33–40
Table 3
Mean zone of inhibition (mm stdev).
Antibacterial assay
Bacteria
Antifungal assay
Ni(dtc)2
Tetracycline
Fungi
Ni(dtc)2
Nystatin
E. coli (mm stdev)
P. aeruginosa (mm stdev)
B. thuringiensis (mm stdev)
25.5 0.5
27.4 0.6
31.0 0.3
17.0 0.5
15.0 0.5
18.0 0.4
A. nigrus (mm stdev)
F. oxysporum (mm stdev)
P. chrysogenum (mm stdev)
21.5 0.5
27.4 0.6
24.0 0.3
18.0 0.4
14.2 0.4
20.0 0.5
[8] S.A.A. Nami, A. Husain, K.S. Siddiqi, B.L. Westcott, K. Kopp-Vaughn,
Spectrochim. Acta, Part A 75 (2010) 444.
[9] M.P. Suh, W. Shin, H. Kim, C.H. Koo, Inorg. Chem. 26 (1987) 1846.
[10] SAINT + Software for CCD Diffractometers; Bruker AXS, Madison, WI, 2000.
[11] G.M. Sheldrick, SADABS Program for Correction of Area Detector Data, University
of Gottingen, Gottingen, Germany, 1999.
[12] (a) SHELXTL Package v. 6.10; Bruker AXS: Madison, WI, 2000.;
G.M. Sheldrick, SHELXS-86 and SHELXL-97, University of Gottingen, Gottingen,
Germany, 1997.
[13] A.L. Spek, PLATON, University of Utrecht, Utrecht, The Netherlands, 2001.
[14] (a) L.J. Farrugia, J. Appl. Crystallogr. 30 (1997) 565;
(b) . Mercury: visualization and analysis of crystal structures:C.F. Macrae, P.R.
Edgington, P. McCabe, E. Pidcock, G.P. Shields, R. Taylor, M. Towler, J. van de
Streek, J. Appl. Crystallogr. 39 (2006) 453.
experiment was performed in triplicate. The radial growth of the
colony was recorded on completion of the incubation, and the
mean diameter was recorded. The complex showed higher activity
against the bacteria and fungi than the known antibiotics. Area of
zone of inhibition was used as a criterion to ascertain the biocidal
activity. The screening data are reported in Table 3. The 20 mm
zone of inhibition represents significant activity, for 10–12 mm
inhibition activity is good, 7–9 mm is low, and below 7 mm the
activity is insignificant. The Ni(dtc)2 shown remarkable antibacte-
rial and antifungal activity against these pathogens.
[15] M. Bonamico, M. Dessy, M. Mariani, A. Vaciago, L. Zambonelli, Acta Crystallogr.,
Sect. 19 (1965) 619.
5. Conclusion
[16] R. Selvaraju, K. Panchanatheswaran, Acta Crystallogr., Sect. C 51 (1995) 606.
[17] M.N.I. Khan, J.P. Fackler Jr., H.H. Murray, D.D. Herich, Acta Crystallogr., Sect. 43
(1987) 1917.
[18] M. Brookhart, M.L.H. Green, G. Parkin, Proc. Natl. Acad. Sci. USA 104 (2007)
6909.
[19] R. Angamuthu, L.L. Gelauff, M.A. Siegler, A.L. Spek, E. Bouwman, Chem.
Commun. (2009) 2700.
[20] J. Perez, A. Espinosa, J.M. Galiana, E. Perez, J.L. Serrano, M.A.G. Aranda, M.
Insausti, Dalton Trans. (2009) 9625.
The crystal structure of nickel(II) bis(N,N-diethyldithiocarba-
mate) has been revisited and refine up to R = 2.99%. This paper
reports a rare Niꢀ ꢀ ꢀH anagostic interaction evidenced by the crystal
structure of Ni(dtc)2. The complex showed higher antibacterial and
antifungal activities than the slandered antibiotics. Ni(dtc)2
showed highest activity for B. thuringiensis and F. oxysporum.
[21] A. John, M.M. Shaikh, R.J. Butcher, P. Ghosh, Dalton Trans. (2010) 7353.
[22] M. Bortoluzzi, G. Paolucci, B. Pitteri, A. Vavasori, V. Bertolasi, Organometallics
28 (2009) 3247.
Acknowledgements
[23] J. Flapper, H. Kooijman, M. Lutz, A.L. Spek, P.W.N.M. van Leeuwen, C.J. Elsevier,
P.C.J. Kamer, Organometallics 28 (2009) 3272.
[24] C. Taubmann, K. Ofele, E. Herdtweck, W.A. Herrmann, Organometallics 28
(2009) 4254.
[25] J. Ruiz, J. Lorenzo, C. Vicente, G. Lopez, J.M. Lopez-de-Luzuriaga, M. Monge, F.X.
Aviles, D. Bautista, V. Moreno, A. Laguna, Inorg. Chem. 47 (2008) 6990.
[26] (a) L. Brammer, Dalton Trans. (2003) 3145;
(b) J.C. Lewis, J. Wu, R.G. Bergman, J.A. Ellman, Organometallics 24 (2005)
5737.
[27] H.V. Huynh, L.R. Wong, P.S. Ng, Organometallics 27 (2008) 2231.
[28] W. Yao, O. Eisenstein, R.H. Crabtree, Inorg. Chim. Acta 254 (1997) 105.
[29] (a) Y. Zhang, J.C. Lewis, R.G. Bergman, J.A. Ellman, E. Oldfield, Organometallics
25 (2006) 3515;
Department of Chemistry, I.I.T, Kanpur India is gratefully
acknowledged for providing single crystal X-ray facility. We are
grateful to the Council of Scientific and Industrial Research, New
Delhi (research scheme No. 21(0685)/07 EMR-II) for the financial
support. One of us (SAAN) thanks Department of Science & Tech-
nology for financial assistance under SERC FAST Scheme, No. SR/
FT/CS-031/2008, NewDelhi, India.
Appendix A. Supplementary data
(b) M. Brookhart, M.L.H. Green, G. Parkin, PNAS 24 (2007) 6908.
[30] R. Taylor, O. Kennard, J. Am. Chem. Soc. 104 (1982) 5063.
[31] A.V. Afonin, S.V. Amosova, V.I. Gostevskaya, G.M. Gavrilova, N.I. Ivanova, A.V.
Vashchenko, Russ. Chem. Bull. 39 (1990) 1796.
[32] MestReC, Mestrelab Research S.L.; Santiago de Compostela, A Coruna, Spain.
[33] (a) Y. Han, H.V. Huynh, L.L. Koh, J. Organomet. Chem. 692 (2007) 3606;
(b) Y. Han, H.V. Huynh, G.K. Tan, Organometallics 26 (2007) 6447.
[34] Y. Han, H.V. Huynh, G.K. Tan, Organometallics 26 (2007) 4612.
[35] E. Bouwman, R.K. Henderson, A.K. Powell, J. Reedijk, W.J.J. Smeets, A.L. Spek, N.
Veldman, S. Wocadlo, Dalton Trans. (1998) 3495.
[36] B. Cvek, V. Milacic, J. Taraba, Q.P. Dou, J. Med. Chem. 51 (2008) 6256.
[37] L. Giovagnini, L. Ronconi, D. Aldinucci, D. Lorenzon, S. Sitran, D. Fregona, J. Med.
Chem. 48 (2005) 1588.
[38] V. Milacic, D. Chen, L. Ronconi, K.R. Landis-Piwowar, D. Fregona, Q.P. Dou,
Cancer Res. 66 (2006) 10478.
[39] M. Viola-Rhenals, M.S. Rieber, M. Rieber, Biochem. Pharmacol. 74 (2007) 841.
[40] D. Saggioro, M.P. Rigobello, L. Paloschi, A. Folda, S.A. Moggach, S. Parsons, L.
Ronconi, D. Fregona, A. Bindoli, Chem. Biol. 14 (2007) 1128.
[41] D. Chen, Q.Z.C. Cui, H.J. Yang, Q.P. Dou, Cancer Res. 66 (2006) 10425.
[42] A. Rehman, M.I. Choudhary, W.J. Thomsen, Bioassay Techniques for Drug
Development, Harwood Academic Publishers, Amsterdam, Netherlands, 2001.
pp. 9–25.
CCDC 682361 contains the supplementary crystallographic data
for Ni(dtc)2. This data can be obtained free of charge via http://
Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ,
UK; fax: (+44) 1223-336-033; or e-mail: deposit@ccdc.cam.ac.uk.
References
[1] G. Hogarth, Prog. Inorg. Chem. 53 (2005) 71.
[2] O. Ates, N. Cesur, H. Guner, M. Uzun, M. Kiraz, D. Kaya, Farmaco 50 (1995) 361.
[3] S. Ozkirimli, T.I. Apak, M. Kiraz, Y. Yegenoglu, Arch. Pharmacal Res. 28 (2005)
1213.
[4] N.S. Gunay, G. Capan, N. Ulusoy, N. Ergenc, G. Otuk, D. Kaya II, Farmaco 54
(1999) 826.
[5] H. Schonenberger, P. Lippert, Pharmazie 27 (1972) 139.
[6] A.F. Vanin, E.V. Faassen, Mononitrosyl-Iron Complexes with Dithiocarbamate
Ligands: Physico-chemical Properties, Radicals for Life: The Various Forms of
Nitric Oxide, Elsevier, Amsterdam, Netherlands, 2007. Chapter 18.
[7] J.R. Dilworth, D.V. Griffiths, S.J. Parrott, Y. Zheng, Dalton Trans. (1997) 2931.